Tazarotene (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Tazarotene drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
| NON-PROPRIETARY NAME: | Tazarotene |
| SUBSTANCE NAME: | TAZAROTENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-03 |
| END MARKETING DATE: | 0000-00-00 |
Tazarotene HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tazarotene from Taro Pharmaceuticals U.S.A., Inc. |
| LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/g) |
| START MARKETING DATE: | 2017-04-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51672-1373_423e1f72-7ad6-4982-946d-197cb19a3b22 |
| PRODUCT NDC: | 51672-1373 |
| APPLICATION NUMBER: | ANDA208258 |
Other TAZAROTENE Pharmaceutical Manufacturers / Labelers:
